Cargando…

Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease

Detalles Bibliográficos
Autores principales:	Takahashi, Hiroto, Xia, Peng, Cui, Jiankun, Talantova, Maria, Bodhinathan, Karthik, Li, Wenjun, Saleem, Sofiyan, Holland, Emily A., Tong, Gary, Piña-Crespo, Juan, Zhang, Dongxian, Nakanishi, Nobuki, Larrick, James W., McKercher, Scott R., Nakamura, Tomohiro, Wang, Yuqiang, Lipton, Stuart A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751459/ https://www.ncbi.nlm.nih.gov/pubmed/26867695 http://dx.doi.org/10.1038/srep20750

Ejemplares similares

Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
por: Takahashi, Hiroto, et al.
Publicado: (2015)

MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model
por: Cho, Eun-Gyung, et al.
Publicado: (2011)

Memantine protects thalamocortical hyper‐glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc(−)
por: Okada, Motohiro, et al.
Publicado: (2019)

Corrigendum: Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system
por: Baxter, Paul S., et al.
Publicado: (2017)

Corrigendum: Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy
por: Chang, Yun-Hsuan, et al.
Publicado: (2017)

CORRIGENDUM: Src tyrosine kinase signaling antagonizes nuclear localization of FOXO and inhibits its transcription factor activity
por: Bülow, Margret H., et al.
Publicado: (2014)

Corrigendum: Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism
por: Musto, Alberto E., et al.
Publicado: (2016)

Corrigendum: Non-ionizing radiofrequency electromagnetic waves traversing the head can be used to detect cerebrovascular autoregulation responses
por: Oziel, M., et al.
Publicado: (2016)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
por: Lopes, João P, et al.
Publicado: (2013)

The effect of the NMDA channel blocker memantine on salicylate-induced tinnitus in rats
por: RALLI, M., et al.
Publicado: (2014)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
por: Osanloo, Naser, et al.
Publicado: (2015)

Transcriptional profiling of MEF2-regulated genes in human neural progenitor cells derived from embryonic stem cells
por: Chan, Shing Fai, et al.
Publicado: (2014)

Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency
por: Nagar, Saumya, et al.
Publicado: (2017)

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
por: Okamoto, Shu-ichi, et al.
Publicado: (2009)

Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease
por: Singh, Satish, et al.
Publicado: (2020)

The Estimated Impact of Drug Importation, Mandatory Mail Service, and Medicaid Fee Reduction on Community Pharmacies in Michigan
por: McKercher, Patrick L.
Publicado: (2006)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi
por: Santos Souza, Higo Fernando, et al.
Publicado: (2019)

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
por: Tu, Shichun, et al.
Publicado: (2017)

Professional CUDA C programming
por: Cheng, John, et al.
Publicado: (2014)

Living on the edge
por: McKercher, Bob, et al.
Publicado: (2006)

The Over-Reaction to SARS and the Collapse of Asian Tourism
por: McKercher, Bob, et al.
Publicado: (2004)

Editorial: Special issue on CAUTHE 2021 conference
por: Scerri, Madalyn, et al.
Publicado: (2022)

Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models
por: Lipton, Stuart A, et al.
Publicado: (2016)

Corrigendum: Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy
por: Cui, Guozhen, et al.
Publicado: (2015)

Computational Modeling of Therapy with the NMDA Antagonist in Neurodegenerative Disease: Information Theory in the Mechanism of Action of Memantine
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult
por: Ferrer-Acosta, Yancy, et al.
Publicado: (2022)

Altered Actions of Memantine and NMDA-Induced Currents in a New Grid2-Deleted Mouse Line
por: Kumagai, Ayako, et al.
Publicado: (2014)

Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer’s Disease, In Silico Trials
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Do destinations have multiple lifecycles?
por: McKercher, Bob, et al.
Publicado: (2021)

Does the environment matter in the ‘new normal’?
por: Mkono, Mucha, et al.
Publicado: (2022)

Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond
por: Hasanagic, Senad, et al.
Publicado: (2020)

Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol
por: Sandström, Katharina O., et al.
Publicado: (2022)

Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a review
por: Bessell, Erica, et al.
Publicado: (2015)

Memantine, an Antagonist of the NMDA Glutamate Receptor, Affects Cell Proliferation, Differentiation and the Intracellular Cycle and Induces Apoptosis in Trypanosoma cruzi
por: Damasceno, Flávia Silva, et al.
Publicado: (2014)

Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats
por: Ndlazi, Ziphozethu, et al.
Publicado: (2018)

NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
por: Ghatak, Swagata, et al.
Publicado: (2021)

Nrf2 and HSF-1 Pathway Activation via Hydroquinone-Based Proelectrophilic Small Molecules Is Regulated by Electrochemical Oxidation Potential
por: Satoh, Takumi, et al.
Publicado: (2015)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
por: Pringle, A, et al.
Publicado: (2012)

Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg(2+) and memantine under conditions of agonist exposure
por: McKay, Sean, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6uv94hbh5ljhv254t141lj9cbv